Salotagi S, Kannan A, Jindal A. Eternal hunt: Unravelling the challenge of CRE, the quest for perfection continues! Indian J Crit Care Med 2024;28(5):513–514.
Baran I, Aksu N. Phenotypic and genotypic characteristics of carbapenem-resistant Enterobacteriaceae in a tertiary-level reference hospital in Turkey. Ann Clin Microbiol Antimicrob 2016;15:20. DOI: 10.1186/s12941-016-0136-2.
Falcone M, Daikos GL, Tiseo G, Bassoulis D, Giordano C, Galfo V, et al. Efficacy of ceftazidime-avibactam plus aztreonam in patients with bloodstream infections caused by metallo-β-lactamase–producing enterobacterales. Clin Infect Dis 2021;72(11):1871–1878. DOI: 10.1093/cid/ciaa586.
Shaw E, Rombauts A, Tubau F, Padullés A, Càmara J, Lozano T, et al. Clinical outcomes after combination treatment with ceftazidime/avibactam and aztreonam for NDM-1/OXA-48/CTX-M-15-producing Klebsiella pneumoniae infection. J Antimicrob Chemother 2018;73(4):1104–1106. DOI: 10.1093/jac/dkx496.
Deo SV, Deo V, Sundaram V. Survival analysis-part 2: Cox proportional hazards model. Indian J Thorac Cardiovasc Surg 2021;37(2):229–233. DOI: 10.1007/s12055-020-01108-7.
